Comprehensive efforts to increase adherence to statin therapy

Alexander Vonbank, Stefan Agewall, Keld Per Kjeldsen, Basil S. Lewis, Christian Torp-Pedersen, Claudio Ceconi, Christian Funck-Brentano, Juan Carlos Kaski, Alexander Niessner, Juan Tamargo, Thomas Walther, Sven Wassmann, Giuseppe Rosano, Harald Schmidt, Christoph H. Saely, Heinz Drexel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

There is compelling evidence that statin therapy improves cardiovascular morbidity and mortality. Unfortunately, statin adherence is far from optimal regarding initiation, execution and persistence of treatment over time.26 Poor adherence to statin therapy is associated with a significantly increased risk of cardiovascular events and mortality. Evidence-based steps to improve adherence are available and should be taken in order to improve patient outcomes. Reinforcing statin adherence appears to have at least as strong beneficial effects as introducing a new drug.

Original languageEnglish
Pages (from-to)2473-2477b
Number of pages7
JournalEuropean Heart Journal
Volume38
Issue number32
DOIs
Publication statusPublished - 21 Aug 2017

Keywords

  • DENSITY-LIPOPROTEIN CHOLESTEROL
  • C-REACTIVE PROTEIN
  • CARDIOVASCULAR-DISEASE
  • PRIMARY NONADHERENCE
  • CLINICAL-PRACTICE
  • MYOCARDIAL-INFARCTION
  • LOWERING MEDICATIONS
  • SECONDARY PREVENTION
  • PATIENT EDUCATION
  • DRUG-THERAPY

Fingerprint

Dive into the research topics of 'Comprehensive efforts to increase adherence to statin therapy'. Together they form a unique fingerprint.

Cite this